Guaifenesin Tablet, Extended Release
Product Images NDC 62207-570

5 FDA label images from Granules India Ltd · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Guaifenesin (NDC 62207-570). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Granules India Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Guaifenesin-er-1200-mg-bulk-label (Guaifenesin Er 1200 mg Bulk Label)

Guaifenesin-er-1200-mg-bulk-label (Guaifenesin Er 1200 mg Bulk Label)
Two white packaging labels for Guaifenesin Extended-Release Tablet 1200 mg. Each tablet contains 1200 mg guaifenesin. Labels show batch number, manufacturing and expiration dates as placeholders, manufacturing license number, NDC number 62207-569-93, storage instructions, caution for repacking only, and country of origin India. Labels include barcodes and details on units and weights.*
FDA Label Image

62207-570-31.jpg (62207 570 31)

62207-570-31.jpg (62207 570 31)
Guaifenesin Extended-Release Tablets 600 mg packaging label manufactured by Granules India Limited. The label shows a pack size of 270 x 20 tablets and includes storage conditions between 20°C to 25°C (68°F to 77°F). It features barcodes, lot number placeholders, and NDC 62207-570-31. The label is printed in English and contains manufacturer address details in India.*
FDA Label Image

70010-569-99.jpg (62207 569 99)

70010-569-99.jpg (62207 569 99)
Guaifenesin Extended-Release Tablets 1200 mg label manufactured by Granules India Limited. The label indicates a pack size of 300 packs with 14 tablets each. Storage instructions specify keeping the product between 20°C to 25°C (68°F to 77°F). The label includes the NDC code 62207-569-99, barcodes, and placeholder fields for expiration date, lot number, and quantity.*
FDA Label Image

70010-570-30 (62207 570 30)

70010-570-30 (62207 570 30)
Label for Guaifenesin Extended-Release Tablet 600 mg. The label includes batch number, manufacturing and expiration dates (placeholders), manufacturing license number, NDC number 62207-570-30, and packaging details indicating 5 units of 4000 tablets each. It specifies storage conditions between 20°C to 25°C, caution for repacking only, and origin as India. The labeler is Granules India Ltd.*
FDA Label Image

70010-570-92.jpg (62207 570 92)

70010-570-92.jpg (62207 570 92)
Text panel for Guaifenesin Extended-Release Tablet 600 mg with details including batch number, manufacturing and expiration dates (placeholders), manufacturing license number, NDC number 62207-570-92, storage instructions (20°C to 25°C), caution for repacking, country of origin India, and labeler Granules India Ltd address.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.